DAC
BIIB icon

Dividend Assets Capital’s Biogen BIIB Stock Holding History

Dividend Assets Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11
Closed -$3K – 485
2023
Q2 		$3K Buy
+11
New +$3.27K ﹤0.01% 469
2014
Q3 		– Sell
-2,106
Closed -$664K – 163
2014
Q2 		$664K Hold
2,106
– – 0.02% 89
2014
Q1 		$644K Hold
2,106
– – 0.02% 93
2013
Q4 		$589K Hold
2,106
– – 0.02% 98
2013
Q3 		$507K Hold
2,106
– – 0.02% 98
2013
Q2 		$453K Buy
+2,106
New +$450K 0.02% 98

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dividend Assets Capital's BIIB Position: Q3 2023 in Review

Dividend Assets Capital sold out of Biogen (BIIB) in Q3 2023, closing a stake of 11 shares — an estimated $3K sold.

Dividend Assets Capital first reported a position in BIIB in Q2 2013 and held it in 6 quarters. The position peaked at $664K in Q2 2014. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Dividend Assets Capital reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Dividend Assets Capital sold 11 Biogen shares in Q3 2023, an estimated $3K.
  • Dividend Assets Capital first reported a position in Biogen in Q2 2013 and held it in 6 quarters.
  • Dividend Assets Capital's Biogen position peaked at $664K in Q2 2014.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Dividend Assets Capital's 13F filing for Q3 2023, filed 26 Oct 2023.